| Schedule of Intangible Assets |
Intangible assets were as follows as of February 29, 2024 and November 30, 2023:
|
|
|
|
|
|
|
|
|
|
|
|
|
Useful lives |
|
February 29, 2024 |
|
|
November 30, 2023 |
|
Patents |
|
10-20 years |
|
$ |
697,744 |
|
|
$ |
697,744 |
|
Less: Intangible asset impairment |
|
|
|
$ |
(377,810 |
) |
|
$ |
(377,810 |
) |
Less: Accumulated amortization |
|
|
|
|
(163,340 |
) |
|
|
(160,434 |
) |
License agreement |
|
10 years |
|
|
474,000 |
|
|
|
474,000 |
|
Less: Intangible asset impairment |
|
|
|
|
(185,000 |
) |
|
|
(185,000 |
) |
Less: Accumulated amortization |
|
|
|
|
(254,469 |
) |
|
|
(248,607 |
) |
Customer relationships – PrepaCyte®CB |
|
15 years |
|
|
41,000 |
|
|
|
41,000 |
|
Less: Intangible asset impairment |
|
|
|
|
(26,267 |
) |
|
|
(26,267 |
) |
Less: Accumulated amortization |
|
|
|
|
(9,704 |
) |
|
|
(9,505 |
) |
Brand |
|
1 year |
|
|
31,000 |
|
|
|
31,000 |
|
Less: Accumulated amortization |
|
|
|
|
(31,000 |
) |
|
|
(31,000 |
) |
Customer relationships – Cord:Use |
|
30 years |
|
|
960,000 |
|
|
|
960,000 |
|
Less: Accumulated amortization |
|
|
|
|
(184,000 |
) |
|
|
(176,000 |
) |
Net Intangible Assets |
|
|
|
$ |
972,154 |
|
|
$ |
989,121 |
|
|